Swedish Registry: PDE5i Erectile Dysfunction Drugs Could Reduce Mortality Risk in Coronary Artery Disease Patients
Phosphodiesterase 5 inhibitor (PDE5i) erectile dysfunction (ED) treatments such as Viagra (sildenafil) could lower mortality risk in men with stable coronary artery disease compared with alprostadil, researchers on a new Swedish registry study from the Karolinska Instituet claim.